GLP-1 Side Effects: Complete Guide & Management Tips

Most GLP-1 side effects are manageable and improve with time. Here is the complete list — what causes them, when they peak, and how to manage each.

The Side Effect Checker Tool

GLP-1 Side Effect Checker

Select what you're experiencing for management tips.

Common GLP-1 Side Effects (Trial Frequency)

Side EffectFrequencyWhen It Peaks
Nausea20-44%Weeks 1-4 and after dose escalations
Diarrhea10-30%First 4-8 weeks
Vomiting5-24%Weeks 1-4
Constipation10-24%Weeks 1-12
Decreased appetiteUniversalThroughout treatment (intended effect)
Fatigue5-15%First 1-3 months
Headache5-14%Variable
Injection-site reactions3-8%Throughout
Hair shedding~3-7%Months 3-6 (telogen effluvium)

Side Effects by Topic

Hair Loss on GLP-1

Hair shedding from GLP-1 weight loss — what causes it, when to worry, and how to prevent it.

GI Side Effects

Nausea, constipation, diarrhea, reflux. Management protocols for each.

Cancer Risk

The thyroid C-cell warning, pancreatic concerns, and what the human evidence actually shows.

Heart & Cardiovascular

Why GLP-1s actually reduce cardiovascular events — the SELECT trial and CV benefits.

When to Call Your Doctor

Most GLP-1 side effects are mild and self-limiting. Contact your prescriber for:

Frequently Asked Questions

What are GLP-1 side effects?
Most common: nausea (44% in trials), diarrhea (30%), vomiting (24%), constipation (24%), decreased appetite, fatigue, and headache. Most peak in weeks 1-4 and after dose escalations, then improve. Serious but rare: pancreatitis, gallbladder disease, kidney injury, thyroid C-cell tumors (animal studies).
Is GLP-1 safe long-term?
GLP-1 medications have been used since 2005 (exenatide). The largest long-term safety dataset is for liraglutide and exenatide. Newer drugs (semaglutide, tirzepatide) have been used since 2017 and 2022 respectively, with growing real-world data. Safety profile is generally favorable for chronic use.
What are GLP-1 long-term side effects?
Long-term concerns: gallbladder disease (mild excess risk), pancreatitis (rare), and an animal-study signal for medullary thyroid carcinoma (boxed warning, not seen in humans). Lean mass loss alongside fat loss is increasingly recognized — strength training and high protein intake mitigate this.
Are GLP-1 drugs safe for the heart?
Yes — and they actually reduce cardiovascular events in patients with established heart disease. The SELECT trial showed Wegovy reduces major cardiovascular events by 20% in adults with obesity + heart disease.
Why am I so tired on GLP-1?
Common causes: reduced calorie intake (most common), low electrolytes from reduced food/fluid intake, low protein intake, and direct medication effect. Solutions: hit 0.7-1g protein per lb of goal weight, drink 2-3L water, take electrolytes (sodium 2-3g/day in early weeks), and ensure adequate calories (don't aim for excessive deficits).